宝济药业挂牌港交所,山东国资多点加码生物医药

大众日报
Dec 12, 2025

12月10日,上海宝济药业股份有限公司(下称“宝济药业”,02659.HK)在香港联交所主板挂牌上市。根据公开信息,自成立以来,该公司已完成多轮融资,累计筹集约15.31亿元,此次全球发售H股3791.17万股,发行价为26.38港元/股,募集资金总额约10亿港元。值得关注的是,山东国资亦在宝济药业的成长过程中持续押注,在创新生物医药领域的布局愈发明确。处于研发投入高峰期根据招股书,宝济药业是一家...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10